A neutrophil cell membrane-biomimetic nanoplatform based on l-arginine nanoparticles for early osteoarthritis diagnosis and nitric oxide therapy

Neutrophile-cell-membrane-based biomimetic nanoparticles were developed for the targeted recognition of inflamed osteoarthritis, dual-modal imaging diagnosis, and NO gas therapy.